These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30660493)

  • 81. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
    Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
    J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance.
    Radtke JP; Boxler S; Kuru TH; Wolf MB; Alt CD; Popeneciu IV; Steinemann S; Huettenbrink C; Bergstraesser-Gasch C; Klein T; Kesch C; Roethke M; Becker N; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
    Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):288-96. PubMed ID: 26078202
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Is prostatic adenocarcinoma with cribriform architecture more difficult to detect on prostate MRI?
    Belue MJ; Blake Z; Yilmaz EC; Lin Y; Harmon SA; Nemirovsky DR; Enders JJ; Kenigsberg AP; Mendhiratta N; Rothberg M; Toubaji A; Merino MJ; Gurram S; Wood BJ; Choyke PL; Turkbey B; Pinto PA
    Prostate; 2023 Dec; 83(16):1519-1528. PubMed ID: 37622756
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance?
    Pepe P; Garufi A; Priolo G; Pennisi M
    World J Urol; 2016 Sep; 34(9):1249-53. PubMed ID: 26699628
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy-naïve patients.
    Borkowetz A; Hadaschik B; Platzek I; Toma M; Torsev G; Renner T; Herout R; Baunacke M; Laniado M; Baretton G; Radtke JP; Kesch C; Hohenfellner M; Froehner M; Schlemmer HP; Wirth M; Zastrow S
    BJU Int; 2018 Jan; 121(1):53-60. PubMed ID: 28921850
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The utility of in-bore multiparametric magnetic resonance-guided biopsy in men with negative multiparametric magnetic resonance-ultrasound software-based fusion targeted biopsy.
    Perrin A; Venderink W; Patak MA; Möckel C; Fehr JL; Jichlinski P; Porcellini B; Lucca I; Futterer J; Valerio M
    Urol Oncol; 2021 May; 39(5):297.e9-297.e16. PubMed ID: 33341358
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Risk-based MRI-directed diagnostic pathway outperforms non-risk-based pathways in suspected prostate cancer biopsy-naïve men: a large cohort validation study.
    Bittencourt LK; Guricova K; Zucker I; Durieux JC; Schoots IG
    Eur Radiol; 2022 Apr; 32(4):2330-2339. PubMed ID: 35028750
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The diagnostic accuracy of multiparametric magnetic resonance imaging before biopsy in the detection of prostate cancer.
    Otti VC; Miller C; Powell RJ; Thomas RM; McGrath JS
    BJU Int; 2019 Jan; 123(1):82-90. PubMed ID: 29804315
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.
    Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H
    BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Accuracy of multiparametric magnetic resonance imaging to detect significant prostate cancer and index lesion location.
    Goldman H; Singh N; Harding C; McGirr J; Seal A; Duncan I; Sowter S
    ANZ J Surg; 2019 Jan; 89(1-2):106-110. PubMed ID: 30257273
    [TBL] [Abstract][Full Text] [Related]  

  • 91. MRI-Targeted Prostate Fusion Biopsy: What Are We Missing outside the Target? Implications for Treatment Planning.
    Oderda M; Dematteis A; Calleris G; Diamand R; Gatti M; Marra G; Adans-Dester G; Al Salhi Y; Pastore A; Faletti R; Gontero P
    Curr Oncol; 2024 Jul; 31(7):4133-4140. PubMed ID: 39057180
    [No Abstract]   [Full Text] [Related]  

  • 92. A Comparison of Cancer Detection Rates Between Template Systematic Biopsies Obtained Using Magnetic Resonance Imaging-Ultrasound Fusion Machine and Freehand Transrectal Ultrasound-Guided Systematic Biopsies.
    Hoge C; Maynor S; Guan T; Naffouje R; Rao M; Verma S; Sidana A
    J Endourol; 2020 Oct; 34(10):1095-1098. PubMed ID: 32631097
    [No Abstract]   [Full Text] [Related]  

  • 93. Multiparametric magnetic resonance imaging for prostate cancer improves Gleason score assessment in favorable risk prostate cancer.
    Kamrava M; Kishan AU; Margolis DJ; Huang J; Dorey F; Lieu P; Kupelian PA; Marks LS
    Pract Radiat Oncol; 2015; 5(6):411-6. PubMed ID: 26059510
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.
    Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A
    Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer?
    Gold SA; Hale GR; Bloom JB; Smith CP; Rayn KN; Valera V; Wood BJ; Choyke PL; Turkbey B; Pinto PA
    World J Urol; 2019 Feb; 37(2):235-241. PubMed ID: 29785491
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Value of MRI/ultrasound fusion in primary biopsy for the diagnosis of prostate cancer].
    Distler F; Radtke JP; Kesch C; Roethke M; Schlemmer HP; Roth W; Hohenfellner M; Hadaschik B
    Urologe A; 2016 Feb; 55(2):146-55. PubMed ID: 26556268
    [TBL] [Abstract][Full Text] [Related]  

  • 97. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
    Moldovan PC; Van den Broeck T; Sylvester R; Marconi L; Bellmunt J; van den Bergh RCN; Bolla M; Briers E; Cumberbatch MG; Fossati N; Gross T; Henry AM; Joniau S; van der Kwast TH; Matveev VB; van der Poel HG; De Santis M; Schoots IG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TB; Rouvière O
    Eur Urol; 2017 Aug; 72(2):250-266. PubMed ID: 28336078
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Transperineal Versus Transrectal Targeted Biopsy With Use of Electromagnetically-tracked MR/US Fusion Guidance Platform for the Detection of Clinically Significant Prostate Cancer.
    Winoker JS; Wajswol E; Falagario U; Maritini A; Moshier E; Voutsinas N; Knauer CJ; Sfakianos JP; Lewis SC; Taouli BA; Rastinehad AR
    Urology; 2020 Dec; 146():278-286. PubMed ID: 32956688
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The Role of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Active Surveillance.
    Ma TM; Tosoian JJ; Schaeffer EM; Landis P; Wolf S; Macura KJ; Epstein JI; Mamawala M; Carter HB
    Eur Urol; 2017 Feb; 71(2):174-180. PubMed ID: 27236496
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results.
    Wysock JS; Mendhiratta N; Zattoni F; Meng X; Bjurlin M; Huang WC; Lepor H; Rosenkrantz AB; Taneja SS
    BJU Int; 2016 Oct; 118(4):515-20. PubMed ID: 26800439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.